REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Icipharm S.A. (Ecuador)

Main Activities: Other Construction Material Merchant Wholesalers
Full name: Icipharm S.A. Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Icipharm S.A. is based in Ecuador. The head office is in Guayaquil. The enterprise currently operates in the Other Construction Material Merchant Wholesalers sector. The company was established on July 06, 2007. 3 (2023) employees currently work for Icipharm S.A.. From the latest financial highlights, Icipharm S.A. reported a net sales revenue drop of 62.41% in 2023. Over the same period, its total assets decreased by 6.89%. The enterprise’s net profit margin increased by 1.46% in 2023.

Headquarters
Av Pedro Men Gilbert 5to Piso, Emporium Bldg. , Floor 503
Guayaquil; Guayas;

Contact Details: Purchase the Icipharm S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Icipharm S.A. report to view the information.
Outstanding Shares:
Purchase the Icipharm S.A. report to view the information.
Registered Capital:
Purchase the Icipharm S.A. report to view the information.
Incorporation Date:
July 06, 2007
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Icipharm S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-62.41%▼
Total operating revenue
-62.41%▼
Operating profit (EBIT)
-25.9%▼
EBITDA
-16.07%▼
Net Profit (Loss) for the Period
-8.75%▼
Total assets
-6.89%▼
Total equity
1.44%▲
Operating Profit Margin (ROS)
2.22%▲
Net Profit Margin
1.46%▲
Return on Equity (ROE)
-0.46%▼
Debt to Equity Ratio
20.45%▲
Quick Ratio
0.3%▲
Cash Ratio
0.06%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo